Substituted benzo(B)thiophene compounds having activity as selective estrogen receptor modulators
AssigneeEli Lilly and Company
InventorsChristopher Randall Schmid, James Patrick Sluka, Kristin Sue Marron
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsChristopher Randall Schmid, James Patrick Sluka, Kristin Sue Marron
Estimating the term…
The present invention provides compounds with nitrogen, sulfur or carbon linked basic side chains of formula ##STR1## where R.sup.1 and R.sup.2 are independently hydrogen, halo, hydroxy, alkoxy, alkylcarbonyloxy, alkoxycarbonyl, alkoxycarbonyloxy, arylcarbonyloxy, aryloxycarbonyloxy, or alkylsulfonyloxy; O--SO.sub.2 --(C.sub.4 -C.sub.6 alkyl), chloro, fluoro, or bromo; W is CHOH, C(O), or CH.sub.2 ; Y is --CH.sub.2 --, --NH--, --NMe--, --S--, --SO.sub.2 --; and R.sup.3 and R.sup.4 are independently hydrogen, alkyl, alkylcarbonyl, alkylamino-carbonyl, or arylcarbonyl, or together with the nitrogen to which they are attached form 1-pyrrolidinyl, 1-piperidinyl, or a 5- or 6-membered imide or cyclic amide ring. The present invention also provides pharmaceutical compositions containing the compounds optionally containing estrogen or progestin, and the use of such compounds, alone, or in combination with estrogen or progestin, for treating osteoporosis, aortal smooth muscle cell proliferation, (particularly restenosis), and estrogen-dependent cancer (particularly breast cancer).
A compound having the formula:
The method of claim 16 wherein said estrogen-dependent cancer is breast cancer.
Dependencies are inferred from the claim text.